Résultats de la recherche - 645 results

Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022

Arch Public Health, Volume 82, Issue 1 (2024) Keywords: adults antibodies Cohort study COVID-19 general population Abstract: BACKGROUND: This study assessed seroprevalence trends of SARS-CoV-2 antibodies ...

be.Prepared: Transition to timely genomic resistance surveillance

years, there has been a major global push to improve whole genome sequencing (WGS) infrastructure in response to the COVID-19 pandemic. SARS-CoV-2 WGS has proven to be highly valuable for public health, ...

NATIONAL SURVEILLANCE OF SARS-COV-2 IN WASTEWATER- How does WBE contribute to the global epidemiologic assessment in Belgium? (September 2020 – 2024)

Coronavirus COVID COVID-19 SARS-CoV-2 Surveillance wastewater wastewater surveillance Abstract: Monitoring coronavirus (SARS-CoV-2) via wastewater analysis enables early detection of the evolution of the viral ...

Influenza like-illness surveillance using a Belgian sentinel network of nursing homes: results of October 2022 onwards

infections place a burden on vulnerable nursing home (NH) populations. We aimed to develop a sentinel network to monitor influenza-like illness (ILI), including COVID-19, among Belgian NH  residents. ...

Prevalence of Healthcare-Associated Infections in Belgian Acute Care Hospitals in 2022: Results of ECDC Point Prevalence Survey

included pneumonia and lower respiratory tract infections (32.8%, including COVID-19 infections at 8.5%), surgical site infections (13.6%), urinary tract infections (18.5%), followed by bloodstream ...

Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.

COVID-19 Europe Humans Influenza, Human Respiratory Syncytial Virus Infections Respiratory Syncytial Virus, Human Seasons Abstract: Since the end of November 2023, the European Mortality Monitoring Network ...

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.

Anthony; Bacci, Sabrina; Kissling, Esther; Nunes, Baltazar; VEBIS‐EHR Working Group Source: Influenza Other Respir Viruses, Volume 18, Issue 4 (2024) Keywords: Aged Aged, 80 and over COVID-19 COVID-19 ...

QR code

QR code for this page URL